TICAGRELOR
Chemical Name | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
CAS Number | 274693-27-5 |
Molecular Formula | C23H28F2N6O4S |
Molecular Weight | 522.568 |
Molecular Structure | |
Packing | 25kg/drum |
Capacity | 5T/M |
Storage | Sealed tightly and stored away from light in a cool and dry place |
Application | Ticagrelor is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y12 receptor. |
SPECIFICATION
Items | Specification |
Appearance | White or almost white to pale pink powder |
Identification | IR: Similar to EP Ticagrelor CRS |
Loss on Drying | ≤0.5% |
Residue on Ignition | ≤0.6% |
Chromatographic Purity | Impurity A≤0.1% Impurity B≤0.1% Impurity C≤0.1% Impurity D≤0.15% Impurity E≤8ppm Single impurity≤0.1% Total Impurities≤1.0% |
Particle Size | D90 ≤10 Micro |
Assay(on dried basis) | 97.5 ~ 102.0% |
Standard | EP&In-house standard |